LGALS3 and type 2 diabetes mellitus: After adjustment for age, sex, traditional CVRF, cancer and eGFR the risk for cardiovascular mortality was elevated by 53% per SD increase of galectin-3 and all-cause mortality was 40% higher in people with T2DM.